| Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer D Öhlund, A Handly-Santana, G Biffi, E Elyada, AS Almeida, ... Journal of Experimental Medicine 214 (3), 579-596, 2017 | 2087 | 2017 |
| Organoid models of human and mouse ductal pancreatic cancer SF Boj, CI Hwang, LA Baker, IIC Chio, DD Engle, V Corbo, M Jager, ... Cell 160 (1), 324-338, 2015 | 2023 | 2015 |
| eIF4A supports an oncogenic translation program in pancreatic ductal adenocarcinoma K Chan, F Robert, C Oertlin, D Kapeller-Libermann, D Avizonis, ... Nature communications 10 (1), 5151, 2019 | 89 | 2019 |
| Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors MSJ McDermott, NA O'Brien, B Hoffstrom, KW Gong, M Lu, J Zhang, T Luo, ... Clinical Cancer Research 29 (11), 2131-2143, 2023 | 13 | 2023 |
| Synergistic combination therapy delivered via layer‐by‐layer nanoparticles induces solid tumor regression of ovarian cancer S Kong, P Moharil, A Handly‐Santana, N Boehnke, R Panayiotou, ... Bioengineering & Translational Medicine 8 (2), e10429, 2023 | 8 | 2023 |
| Development and characterization of a novel anti-CLDN6 antibody drug conjugate for the treatment of CLDN6 positive cancers MS McDermott, KW Gong, NA O'Brien, D Conklin, B Hoffstrom, M Lu, ... Cancer Research 82 (12_Supplement), 342-342, 2022 | 1 | 2022 |
| Abstract B16: using human patient-derived organoids to identify genetic dependencies in pancreatic cancer LA Baker, H Tiriac, V Corbo, SF Boj, C Hwang, IIC Chio, DD Engle, ... Clinical Cancer Research 22 (16_Supplement), B16-B16, 2016 | 1 | 2016 |
| Abstract B055: Identifying compounds to promote apoptotic cell death in clear cell ovarian cancer B Shay, A Handly-Santana, X Qin, J Choniere, K Sarosiek, JS Brugge, ... Cancer Research 84 (5_Supplement_2), B055-B055, 2024 | | 2024 |
| Distinct populations of inflammatory fibroblasts and myofibroblasts in D Öhlund, A Handly-Santana, G Biffi, E Elyada | | 2017 |
| Abstract B73: Pancreatic stellate cell heterogeneity in cancer D Öhlund, A Handly-Santana, E Elyada, G Biffi, DA Tuveson Cancer Research 76 (24_Supplement), B73-B73, 2016 | | 2016 |
| Abstract B64: Using pancreatic organoids to infer therapeutic resistance and sensitivity H Tiriac, M Ponz-Sarvise, V Corbo, KK Frese, DD Engle, D Ohlund, T Oni, ... Cancer Research 76 (24_Supplement), B64-B64, 2016 | | 2016 |
| Pancreatic stellate cell heterogeneity in cancer D Öhlund, A Handly-Santana, E Elyada, G Biffi, DA Tuveson Pancreatology 16 (3, Sup), S15, 2016 | | 2016 |
| Pancreatic ductal organoids as a new platform for drug discovery M Ponz-Sarvise, V Corbo, D Ohlund, T Oni, A Handly-Santana, D Engle, ... European Journal of Cancer 50, 63-63, 2014 | | 2014 |
